treatment-free intervals for patients with myeloma
Published 3 years ago • 111 plays • Length 4:10Download video MP4
Download video MP3
Similar videos
-
4:02
treatment-free intervals: what is best for patients?
-
4:42
optimizing myeloma treatment for frail patients: dosing, scheduling and administration
-
2:17
advancements in quadruplet regimens for the treatment of multiple myeloma
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
2:05
emerging therapeutic challenges to treating patients with multiple myeloma
-
1:03
quadruplet regimens for patients with transplant-ineligible multiple myeloma
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
0:46
is there potential for the use of combination therapies in sickle cell disease?
-
1:35
rationale for using immunotherapies in the frontline treatment of multiple myeloma
-
3:43
mrd-guided treatment cessation in multiple myeloma
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
3:46
the current landscape of treatment for frail myeloma patients at relapse & challenges in this space
-
1:14
prevention & monitoring of infections in patients with multiple myeloma treated with immunotherapies
-
2:15
vipor: a multi-targeted therapy for the treatment of r/r dlbcl
-
2:30
a new era of treatment for multiple myeloma
-
1:41
innovative treatment strategies for multiple myeloma
-
2:16
the impact of autosct on disease burden in patients with myeloma treated with quadruplet therapy
-
1:29
managing toxicities associated with immunotherapy in multiple myeloma
-
3:02
optimal treatment strategies for multiple myeloma